semaglutide similar to ozempic vs. Wegovy vs. Mounjaro: What's the Difference? Medications like Semaglutide and Tirzepatide

Nivaan Health selected tirzepatide for its dual GIP/GLP-1 receptor mechanism, which clinical data associates with fewer gastrointestinal side effects and greater weight reduction compared to single-receptor GLP-1 agonists

(2022) 8:e08799

Zhao Y, Zhang YN, Wang KT, Chen L

While factors like dosage, starting weight, and lifestyle habits influence weight loss on GLP-1 medications, research shows changes can be noticeable within the first few weeks and continue as dosage is adjusted

Speculative For a public figure whose transformation timeline overlaps with the post-2021 Wegovy approval period, the possibility of GLP-1 use is clinically plausible in the same way it is plausible for any adult who lost significant weight after 2021